Article

Effect of Antenatal Corticosteroids on Respiratory Morbidity in Singletons After Late-Preterm Birth

Department of Obstetrics and Gynecology, Columbia University, New York, New York 10032, USA.
Obstetrics and Gynecology (Impact Factor: 4.37). 03/2012; 119(3):555-9. DOI: 10.1097/AOG.0b013e31824758f6
Source: PubMed

ABSTRACT To evaluate whether neonates born to women who previously had received antenatal corticosteroids and then delivered a late-preterm-birth neonate had less respiratory morbidity compared with those not exposed to antenatal corticosteroids.
This is a secondary analysis from a multicenter observational study regarding mode of delivery after previous cesarean delivery. We compared women who received one course of antenatal corticosteroids with unexposed parturients and evaluated various respiratory outcomes among those having a singleton, late-preterm-birth neonate. We controlled for potential confounders including gestational age at delivery, diabetes, mode of delivery, and maternal race.
Five thousand nine hundred twenty-four patients met the inclusion criteria; 550 received steroids and 5,374 did not. In the univariable model, compared with unexposed women, those who received antenatal corticosteroids appeared more likely to have neonates who required ventilatory support (11.5% compared with 8.6%, P=.022), had respiratory distress syndrome (RDS) (17.1% compared with 12.2%, P=.001), developed transient tachypnea of the newborn (12.9% compared with 9.8%, P=.020), or required resuscitation in the delivery room (55.8% compared with 49.7%, P=.007). After controlling for confounding factors, we found no significant differences among the groups regarding all of the above outcomes with an odds ratio for RDS of 0.78 (95% confidence interval, 0.60-1.02) and ventilator support of 0.75 (95% confidence interval, 0.55-1.03).
Exposure to antenatal corticosteroids does not significantly affect respiratory outcomes among those with a subsequent late-preterm birth.

Download full-text

Full-text

Available from: Cynthia Gyamfi, Jul 28, 2015
2 Followers
 · 
127 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this study was to determine whether acute histologic chorioamnionitis is associated with adverse neonatal outcomes in late preterm infants who were born after preterm PROM. The relationship between the presence of acute histologic chorioamnionitis and adverse neonatal outcome was examined in patients with preterm PROM who delivered singleton preterm newborns between 34 weeks and 36 6/7 weeks of gestation. Nonparametric statistics were used for data analysis. The frequency of acute histologic chorioamnionitis was 24% in patients with preterm PROM who delivered preterm newborns between 34 weeks and 36 6/7 weeks of gestation. Newborns born to mothers with histologic chorioamnionitis had significantly higher rates of adverse neonatal outcome (74% vs 51%; p<0.005) than those without histologic chorioamnionitis. This relationship remained significant after adjustment for gestational age at preterm PROM, gestational age at delivery, and exposure to antenatal corticosteroids. The presence of acute histologic chorioamnionitis is associated with adverse neonatal outcome in late preterm infants born to mothers with preterm PROM.
    PLoS ONE 12/2013; 8(12):e79941. DOI:10.1371/journal.pone.0079941 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Preterm birth is a leading cause of perinatal mortality and morbidity and continues to be one of the most common complications plaguing obstetrics and neonatology. Primary prevention of preterm birth remains the ultimate but elusive goal. However, efforts to curtail the impact of preterm birth are of great importance. Use of antenatal corticosteroids (ACSs) in threatened preterm labor has been one of the landmark interventions that have improved the neonatal outcome. Since the start of use of ACS: the acceptance has increased dramatically and now it has become the standard of care in threatened preterm labor. However, there are still many unresolved issues surrounding the usage of ACS. In this article, we attempt to synthesize the current available evidence and its application in our daily clinical scenarios.
    Expert Review of Obstetrics &amp Gynecology 01/2014; 8(6). DOI:10.1586/17474108.2013.842688
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Late preterm infants (34-36weeks gestation) have a morbidity rate significantly higher than those born at term. However, few interventions have been undertaken to reduce this increased morbidity and mortality. Antenatal corticosteroid administration could be an effective preventive measure. The aim of this study was to describe the morbidity associated with late prematurity in our institution, and determine if there are differences between those who received antenatal corticosteroids. A prospective observational study was conducted on late preterm infants born in a tertiary hospital from October 2011 until September 2012. Two groups were formed according to whether or not they had received antenatal steroids. The rates of morbidity and mortality for each of the groups were analysed and compared. There was a total of 4127 live newborns during the study period, of whom 3795 were term and 332 were preterm (the overall prematurity rate was 8.04%). There were 247 late preterm deliveries, representing 6% of live born infants, and 74.4% of all premature infants. Of late preterm infants, 63.2% were admitted to the Neonatal Unit and 29.6% had received antenatal steroids. The incidence of admission to the Neonatal Unit and Neonatal Intensive Care, transient tachypnea, need for respiratory support in the form of continuous positive pressure airway and oxygen therapy, incidence of hypoglycemia, feeding difficulty, and jaundice requiring phototherapy were significantly higher (P<.05) in the late preterm group that did not receive antenatal steroids. Our finding suggests that the administration of antenatal corticosteroids to patients at risk of 34-36weeks delivery could significantly reduce the cost and acute morbidity associated with late preterm birth.
    Anales de Pediatría 03/2014; 81(6). DOI:10.1016/j.anpede.2014.01.003 · 0.72 Impact Factor
Show more